Systematic Characterization of Prognostic Values of Peroxiredoxin Family in Gastric Cancer

Table 2

Association between PRDX expression and OS in GC patients with different Lauren classifications.

PRDXs	Lauren classification	Cases	Low	High	HR (95% CI)	value
PRDX1	Intestinal	320	160	160	0.56 (0.41–0.78)	<0.001
	Diffuse	241	120	121	0.59 (0.42–0.84)	0.003
	Mixed	32	16	16	0.75 (0.27–2.06)	0.571
PRDX2	Intestinal	320	160	160	0.47 (0.34–0.65)	<0.001
	Diffuse	241	120	121	0.99 (0.70–1.39)	0.949
	Mixed	32	16	16	1.24 (0.44–3.52)	0.680
PRDX3	Intestinal	320	160	160	0.59 (0.43–0.81)	<0.001
	Diffuse	241	120	121	0.66 (0.47–0.93)	0.017
	Mixed	32	16	16	0.53 (0.19–1.50)	0.222
PRDX4	Intestinal	320	160	160	0.76 (0.55–1.04)	0.088
	Diffuse	241	120	121	0.72 (0.51–1.01)	0.054
	Mixed	32	16	16	0.51 (0.18–1.44)	0.197
PRDX5	Intestinal	269	134	135	0.92 (0.64–1.32)	0.640
	Diffuse	240	120	120	0.85 (0.61–1.20)	0.360
	Mixed	29	14	15	1.22 (0.41–3.65)	0.721
PRDX6	Intestinal	320	160	160	0.67 (0.49–0.92)	0.012
	Diffuse	241	120	121	0.86 (0.61–1.21)	0.384
	Mixed	32	16	16	1.51 (0.54–4.26)	0.429